SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Encysive Pharmaceuticals (ENCY) -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (12)1/9/2006 7:54:31 AM
From: rkrw  Read Replies (1) | Respond to of 205
 
150 patients for pah sounds like it could be a phase III.

ardm device is a follow on strategy. Less puffs.

Think of inhaled prostacyclin as a bridge before having to go on continuous infusion drugs.

Virtually all patients will be on combinations of any two or even three. Pick one of traceer, thelin, ambritensan. Pick viagra or cialis. Pick ventavis or inhaled remodoulin.